Table 1 Clinical characteristics of patients at study enrollment
From: Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation
Patient characteristics | Cohort I | Cohort II |
|---|---|---|
Number of patients (n) | 15 | 19 |
Age, years, median (IQR) | 72 (48 to 77) | 69 (45 to 73) |
Gender male, n (%) | 8 (53.3) | 13 (68.4) |
ICU survivor, n (%) | 10 (66.7) | 12 (63.2) |
28-day survivors, n (%) | n.d. | 14 (73.7) |
90-day survivors, n (%) | n.d. | 7 (36.8) |
APACHE-II, median (IQR) | 24 (18 to 30) | 19 (15 to 26) |
SAPS-II, median (IQR) | 44 (33 to 73) | 44 (34 to 52) |
SOFA, median (IQR) | 10 (6 to 13) | 10 (6 to 11) |